Renal · Year 2 · from Renal
Case 3: Analgesic Nephropathy
Patient Presentation
Demographics: 58-year-old female
Chief Complaint: Chronic headache management and rising creatinine
History of Present Illness: The patient has a long history of chronic daily headaches and has used over-the-counter analgesics daily for over 20 years. She estimates she has taken combination products containing acetaminophen, aspirin, and caffeine (similar to Excedrin) almost daily. She now presents with gradually declining kidney function noted over the past 2 years.
Past Medical History:
- Chronic daily headaches
- Hypertension (difficult to control)
- History of kidney stones
- Recurrent UTIs
Physical Examination:
- Blood pressure: 156/94 mmHg
- General: Well-appearing
- Cardiovascular: Regular, no murmurs
- Abdomen: Non-tender
- No edema
Workup and Results
Laboratory Studies:
- Creatinine: 2.4 mg/dL (was 1.8 mg/dL 1 year ago)
- BUN: 36 mg/dL
- Potassium: 4.2 mEq/L
- Bicarbonate: 20 mEq/L (mild acidosis)
- Urinalysis: 1+ protein, no blood, WBC 5-10/hpf
- Urine concentrating ability: Impaired (max 450 mOsm/kg)
CT Urogram:
- Bilateral small kidneys with irregular contours
- Papillary calcifications
- "Bumpy" kidney contour suggesting papillary necrosis
Clinical Image
CT scan demonstrating bilateral small kidneys with irregular contours and papillary calcifications characteristic of analgesic nephropathy with papillary necrosis.
Diagnosis
Chronic Tubulointerstitial Nephritis due to Analgesic Nephropathy
Features:
- >20 years of daily combination analgesic use
- Bilateral small, irregular kidneys
- Papillary necrosis
- Concentrating defect
- History of UTIs and stones
Discussion
This case illustrates analgesic nephropathy:
- Papillary Necrosis: The lecture describes how chronic analgesic use, particularly combination products, causes papillary necrosis. The renal papilla is particularly susceptible due to its concentrated, hypoxic environment.
- Mechanism: Combination products (especially those with caffeine) are more nephrotoxic than single agents. Prostaglandin inhibition leads to medullary ischemia.
- Clinical Features: The lecture notes that chronic tubulointerstitial disease presents with concentrating defects (polyuria, nocturia), mild proteinuria (<2 g/day), and relatively early anemia for GFR level.
- Associated Conditions: Analgesic nephropathy is associated with increased risk of transitional cell carcinoma of the urinary tract.
Treatment Plan
- Discontinue All Analgesics:
- Stop combination products immediately
- Seek alternative headache management (neurology referral)
- Blood Pressure Control:
- Target <130/80 mmHg
- ACE inhibitor for proteinuria
- Supportive Care:
- Avoid NSAIDs
- Adequate hydration
- Cancer Surveillance:
- Annual urinalysis and cytology
- Increased transitional cell carcinoma risk
- CKD Management:
- Monitor progression
- Standard CKD care
Teaching Points
- Analgesic nephropathy characteristically causes papillary necrosis
- Combination analgesics (especially with caffeine) are more nephrotoxic
- Chronic tubulointerstitial disease causes concentrating defects early
- Aristolochic acid and analgesic nephropathy increase urothelial cancer risk
Image Reference
For visual reference of tubulointerstitial disease concepts, see:
- Radiopaedia: Acute interstitial nephritis - Pathology
- Wikimedia Commons: Papillary necrosis - Imaging
- Radiopaedia: Papillary necrosis - CT findings
Learning Points
- AIN Triad is Rare: Fever, rash, and eosinophilia occur together in <10% of drug-induced AIN
- PPI Latency: PPI-induced AIN has delayed onset (weeks to months) unlike antibiotics (1-3 weeks)
- Gitelman vs Bartter: Hypocalciuria and hypomagnesemia distinguish Gitelman (DCT) from Bartter (TAL)
- TIN Features: Mild proteinuria (<2 g/day), WBC casts, concentrating defects, disproportionate anemia
- Papillary Necrosis Causes: Analgesics, diabetes, sickle cell, obstruction, pyelonephritis (mnemonic: POSTCARD - Pyelonephritis, Obstruction, Sickle cell, TB, Cirrhosis, Analgesics, Renal vein thrombosis, Diabetes)